LADENBURG THALMANN FINANCIAL SERVICES INC. - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$0
-100.0%
8000.0%0.00%
Q3 2019$1,000
-50.0%
8000.0%0.00%
Q2 2019$2,000
-33.3%
8000.0%0.00%
Q1 2019$3,0008000.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Yu Fan 269,544$213,0000.35%
Southland Equity Partners LLC 12,030$9,5640.01%
Sugarloaf Wealth Management, LLC 15,750$13,0000.00%
Frontier Wealth Management LLC 25,000$20,0000.00%
Renaissance Technologies 2,832,739$2,252,0000.00%
UBS Group AG 5,999$5,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 17,984$14,0000.00%
TWO SIGMA INVESTMENTS, LP 106,341$85,0000.00%
OSAIC HOLDINGS, INC. 29,477$24,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders